Výsledky vyhledávání - "Fatemeh Masropour"

Akademický článek

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Autor: Michael Davies, James Welsh, Dawei Chen, Vivek Verma, Maria Angelica Cortez, Yun Hu, Hampartsoum B Barsoumian, Grant Fischer, Liangpeng Yang, Ahmed I Younes, Fatemeh Masropour, Katherine Klein, Christopher Vellano, Joseph Marszalek

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

Background Despite outstanding responses to anti-PD-1 agents in a subset of non-small cell lung cancer (NSCLC) patients, approximately 80% of patients fail to have prolonged favorable response. Recent studies show that tumor cell oxidative metabolism

Externí odkaz: https://doaj.org/article/7e5cf1c73c934075a94ee87b0589162f

Zobrazit plný text záznamu

Supplementary Figures from SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

Autor: James W. Welsh, Maria Angelica Cortez, Katherine Klein, Tugce Ozgen, Sara Mosaffa, Fatemeh Masropour, Mark Wasley, Hari Menon, Yun Hu, Vivek Verma, Ahmed I. Younes, Liangpeng Yang, Hampartsoum B. Barsoumian, Dawei Chen

Supplementary Figures

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f95625e3541384be46a8ffa61c5569c
https://doi.org/10.1158/2326-6066.22543947

Zobrazit plný text záznamu

Data from SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

Immune checkpoint inhibitors, such as anti–PD-1/PD-L1, have emerged as promising therapies for advanced non–small cell lung cancer (NSCLC). However, approximately 80% of patients do not respond to immunotherapy given alone because of intrinsic or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda51812534a46937fc87a65c71cbc67
https://doi.org/10.1158/2326-6066.c.6550473

Zobrazit plný text záznamu

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

Autor: Yun Hu, Maria Angelica Cortez, Sara Mosaffa, Mark Wasley, Hari Menon, Ahmed I. Younes, Tugce Ozgen, Hampartsoum B. Barsoumian, Fatemeh Masropour, L. Yang, Vivek Verma, James W. Welsh, Dawei Chen, Katherine Klein

Publikováno v: Cancer Immunol Res

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c76daf653a436a909ada78d815d3f77
https://doi.org/10.1158/2326-6066.cir-19-0744

Zobrazit plný text záznamu

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Autor: Maria Angelica Cortez, Yun Hu, Ahmed I. Younes, Dawei Chen, Grant M. Fischer, Katherine Klein, Joseph R. Marszalek, Fatemeh Masropour, L. Yang, Christopher P. Vellano, Vivek Verma, James W. Welsh, Hampartsoum B. Barsoumian, Michael Davies

Publikováno v: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

BackgroundDespite outstanding responses to anti-PD-1 agents in a subset of non-small cell lung cancer (NSCLC) patients, approximately 80% of patients fail to have prolonged favorable response. Recent studies show that tumor cell oxidative metabolism

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4de54713bc2ba7716b3f662587bf0b8
https://doi.org/10.1136/jitc-2019-000289

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání